Case report: Nocardia farcinica pneumonia in early-stage post liver transplantation
Background Liver transplantation is a well-established treatment for end-stage liver disease. The evolution of immunosuppressants has supported the recent advances in this field. However, this leads to immunosuppression and increases the risk for infections. Nocardia is an aerobic gram-positive baci...
Saved in:
Published in | Frontiers in medicine Vol. 9 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
07.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
Liver transplantation is a well-established treatment for end-stage liver disease. The evolution of immunosuppressants has supported the recent advances in this field. However, this leads to immunosuppression and increases the risk for infections. Nocardia is an aerobic gram-positive bacillus, which can cause multi-systemic or multi-organ infections. Nocardia is an opportunistic pathogen that principally affects immunosuppressed patients.
Case presentation
Herein, we present a case of Nocardia farcinica pneumonia in a patient at early-stage post-liver transplantation. Following appropriate microbiological tests and imaging, the diagnosis was finally confirmed. A full recovery was achieved after optimal antibiotic therapy of sulfamethoxazole, minocycline, and amikacin.
Conclusions
Nocardia farcinica pneumonia is a rare and life-threatening disease, especially in patients after liver transplantation. Imaging and microbiological tests are helpful for the early diagnosis of the disease. Trimethoprim-sulfamethoxazole (TMP-SMX) as part of first-line therapy for nocardiosis is recommended. |
---|---|
Bibliography: | This article was submitted to Pathology, a section of the journal Frontiers in Medicine Edited by: Mehdi Mirsaeidi, University of Florida, United States These authors have contributed equally to this work and share first authorship Reviewed by: Leela Krishna Teja Boppana, University of Florida College of Medicine - Jacksonville, United States; Chih-Cheng Lai, Chi Mei Medical Center, Taiwan |
ISSN: | 2296-858X 2296-858X |
DOI: | 10.3389/fmed.2022.996045 |